Autonomous driving paper index
From fragmented neurotechnologies to closed-loop brain health systems: integrating artificial intelligence, digital health, digital twins, and advanced materials for brain disorders
One-line summary
Brain disorders have traditionally been managed through fragmented clinical pathways in which diagnosis, monitoring, intervention, and long-term follow-up are treated as separate processes.
Engineering notes
Key topics: autonomous driving. See the paper for implementation details and experimental results.
Chinese explanation / 中文解读
中文解读待补充：本站会优先为端到端自动驾驶、BEV感知、3D目标检测、轨迹预测、路径规划、LiDAR感知等高价值论文补充中文说明。
Original abstract
Brain disorders have traditionally been managed through fragmented clinical pathways in which diagnosis, monitoring, intervention, and long-term follow-up are treated as separate processes. This paradigm is increasingly insufficient for conditions such as Alzheimer’s disease, Parkinson’s disease, stroke, traumatic brain injury, glioma, epilepsy, and neuropsychiatric disorders, whose trajectories are dynamic, heterogeneous, and strongly shaped by biological, behavioral, environmental, and health-system factors. Recent advances in artificial intelligence, digital health, digital twin modeling, and advanced biomaterials provide an opportunity to move beyond isolated technological applications toward integrated brain health systems. In this Perspective, we argue that the major translational opportunity is not simply to apply artificial intelligence to neuroimaging, use wearable devices for neurological monitoring, or develop biomaterials for brain repair in parallel. Rather, the field should aim to build closed-loop systems in which computational models identify disease states, digital platforms continuously update patient trajectories, and advanced materials deliver adaptive therapeutic or regenerative interventions. We propose that future progress depends on three related shifts: moving from episodic diagnosis to longitudinal brain-state modeling; redefining advanced materials as programmable therapeutic interfaces rather than passive carriers; and evaluating success at the level of health-system integration rather than single-device performance. This framework may help reorient brain disease innovation from fragmented neurotechnologies toward clinically deployable, patient-specific, and dynamically adaptive brain health systems.
Links and sources
Need this topic turned into a technical roadmap?
Full Self Driving can prepare a custom autonomous driving literature review, code map, dataset map, and B2B technology assessment.
Request B2B research
Comments